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Background: Repeated and long hospitalizations of cancer patients at the end of life have been suggested as
indicators of low quality of palliative care. Comparing the care delivered between different countries with the
help of these quality indicators may identify opportunities to improve practice. Our objective is twofold: firstly, to
describe the scores for the existing quality indicators “the percentage of time spent in hospital” and “the proportion
of adult patients with more than one hospitalization in the last 30 days of life” in populations of cancer patients in
four European countries and to see whether these countries met previously defined performance standards;
secondly, to assess whether these scores are related to receiving palliative care from their GP.
Methods: A mortality follow-back study was conducted, based on data recorded by representative GP networks for
samples of cancer patients living at home who died non-suddenly in Belgium (n = 500), the Netherlands (n = 310),
Italy (n = 764), and Spain (n = 224).
Results: The quality indicator score for “the percentage of time spent in hospital” in the last month of life was
14.1% in the Netherlands, 17.7% in Spain, 22.2% in Italy, and 24.6% in Belgium, which means that none of the
countries met the performance standard of <10%. For the “proportion of patients with more than one
hospitalization in the last 30 days of life”, two countries met the performance standard of <4%: the Netherlands
(0.6%) and Italy (3.1%). Spain had a score of 4.0% and Belgium scored 5.4%. When patients received palliative care
from their GP, significantly less time was spent in hospital in the last month and fewer hospitalizations took place.
Conclusions: European countries differ regarding the frequency and duration of hospitalizations of cancer patients
in the last month of life. This reflects country-specific differences in the organization of palliative care and highlights
the important role of the GP in palliative care provision.
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High rates of hospitalization at the end of life may be an
indication that palliative care is of suboptimal quality,
since these hospitalizations can be associated with offer-
ing aggressive and futile treatments [1,2], with too much
focus on life prolongation rather than the patient’s
quality of life and the relief of symptom burden, with
inadequate communication about the patient’s care
preferences or with the limited availability or use of pal-
liative home-care services [3]. Although some hospitali-
zations may be inevitable [4,5], there may be potential to
reduce the number and duration of hospitalizations [6],
e.g. by providing appropriate support from general prac-
titioners [1,7].
Long or repeated hospital admissions at the end of life
have been suggested as indicators that palliative care is
of a poor quality [1,8,9]. Several quality indicators for
palliative care concerning the frequency and duration of
hospitalizations at the end of life have already been
developed [1,9-12]. Measuring these quality indicators
can give insights into areas where the quality of care is
not optimal, subsequently enabling priorities to be set
for quality improvement [12]. In this study, we used two
quality indicators regarding hospitalizations, selected
specifically because they could be derived from the
existing data records of general practitioners (GPs) in
Belgium, the Netherlands, Italy, and Spain. The first is
“the percentage of time spent in hospital”, coming from
a set of quality indicators developed in Italy for palliative
home care [9]. The second quality indicator used concerns
“the proportion with more than one hospitalization in the
last 30 days of life”. This quality indicator is part of an in-
dicator set that was developed in the United States for
cancer patients [1,10,11]. These indicators have specific
performance standards: namely that less than 4% of cancer
patients should have more than one hospitalization in the
last month of life [10] and that less than 10% of time
should be spent in hospital [9]. Using these existing indi-
cators, instead of constantly developing new indicators for
palliative care offers advantages. In this case, deriving
these indicators from data collected by existing registra-
tions by GPs, we further tested the usefulness of these in-
dicators in international comparative research.
Comparing the care delivered between different coun-
tries may help identify opportunities to improve practice
[13], particularly when the comparison includes an in-
vestigation of the factors that are associated with poor
or better quality indicator scores. In this paper, we there-
fore also look at whether there is a relationship with the
delivery of palliative care by GPs. Previous studies have
shown that the provision of palliative care by GPs is
associated with less time spent in hospital and fewer
hospitalizations [4,5]. It is also important to examine
whether there is a relationship with GP provision ofpalliative care because the roles of GPs differ between
countries. In some countries, like the Netherlands and
Spain, GPs function as gatekeepers [14] to hospital care:
except in very acute situations, patients need a formal
referral from the GP to see a medical specialist in a hos-
pital. Hence, this provides an opportunity for preventing
avoidable hospitalizations. Although GPs in Belgium and
Italy do not have this strict gatekeeper function, they are
still central professionals in the healthcare system and
have a coordinating role, since most people have their
“own” GP whom they consult when they have medical
problems [15]. Another aspect of the GP’s function that
differs between countries is their role in the provision of
palliative care. In the Netherlands, the GP plays a central
role in the delivery of generalist palliative care at home
[16-18]. In the other three countries, the GP shares the
responsibility of palliative care delivery with generalist or
specialist palliative-care home teams [14,15,18-20].
This paper addresses the following research questions:
1) What is a) the percentage of time spent in hospital
in the last month of life, and b) the proportion of
cancer patients with more than one hospitalization
in the last 30 days of life who lived at home and
who died non-suddenly in Belgium, the Netherlands,
Italy, or Spain?
2) Do the countries meet the performance standards
defined for these two quality indicators?
3) Do these quality indicator scores differ between the
cancer patients who received palliative care from
their general practitioner and those who did not
receive palliative care from their GP?
Methods
Study design
This paper is based on data from the European Sentinel
GP Networks Monitoring End-of-Life Care (EURO
SENTI-MELC) study, a mortality follow-back study on
monitoring end-of-life care in Belgium, the Netherlands,
Spain, and Italy. For this study, we used data from the
nationally representative GP networks [14] collected in
2009 (all countries except Spain), 2010 (all four coun-
tries) and 2011 (Spain only). The GP sentinel networks
cover 1.8% and 0.8% of the Belgian and Dutch national
populations respectively [14,21,22]. In Spain, the two
sentinel networks involved in this study account for
3.5% of the patient population in the Castilla y León re-
gion (in the northwest) and 2.2% in the Comunitat
Valenciana region (in the east) [14,23]. The Italian data
came from a new GP network set up for this study [24]
and were collected from nine of the 146 health districts,
covering about 4% of the national patient population
[14]. The participating GPs in all four countries were
representative for the general population of GPs in each
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in terms of age, gender, and geographical distribution
[14,25,26].
Study population
Since one of the two quality indicators selected was de-
veloped for a cancer population and the other for a
population receiving home care, we decided to focus on
a population of cancer patients who lived at home in the
last month of life. The data were analyzed of deceased
adult cancer patients (aged 18 and above), who had died
non-suddenly according to their GP. Since this study ex-
amines the care delivered at the end of life, the data of
people who died suddenly and unexpectedly according
to their GP were excluded, leaving a population that was
eligible for palliative care [21].
Data collection
In the EURO SENTI-MELC study, GPs recorded the
characteristics of recently deceased patients on a weekly
basis using a standardized questionnaire. Recall bias was
minimized by requiring data entry to be no more than
one week after the GP had been informed of the pa-
tient’s death [14]. In the questionnaire, GPs were asked
about the place of death and place(s) of residence in the
last three months before death, as well as the length of
stay in specific care settings in the last 30 days before
death. Thus, the number of hospitalizations and the
length of stay in hospital in the last month of life could
be deduced. GPs were asked to indicate whether they
provided palliative care by the following question: “Did
you provide palliative care to this patient?” [“no”; “yes,
but not until death”; “yes, until death” (dichotomized
into “yes” and “no”)].
Informed consent and patient anonymity
After being informed of the objectives and procedures of
the study, participating GPs gave written informed con-
sent at the beginning of each registration year. Strict
procedures regarding patient anonymity were employed
during data collection and entry; every patient was
assigned an anonymous reference code by their GP and
any identifying patient and GP data (such as date of
birth, postcode, and GP identification number) were re-
placed with aggregate categories or anonymous codes.
Ethical approval
The protocol of this study was approved by the Ethical
Review Board of Brussels University Hospital of the
Vrije Universiteit Brussel (2004), Belgium, and the Local
Ethical Committee, ‘Comitato Etico della Azienda U.S.L. n.
9 di Grosseto’ (2008), Tuscany, Italy. In the Netherlands
and Spain, no ethical approval is required for the posthu-
mous collection of anonymous patient data.Statistical analysis
The quality indicator “the percentage of time spent in
hospital” is calculated using “number of days in hospital
during home palliative care” as the numerator and “the
total number of days of home palliative care” as the de-
nominator. The performance standard “less than 10% of
time should be spent in hospital” [9] was originally spe-
cified for patients who received home palliative care. In
this study, it is calculated for the last month of life,
for cancer patients regardless of whether they received
home palliative care. The second quality indicator, “the
proportion with more than one hospitalization in the
last 30 days of life”, was calculated using “the number of
patients who died from cancer and had more than one
hospitalization in the last 30 days of life” as the numerator
and “the number of patients who died from cancer” as the
denominator. We used the original performance standard:
“less than 4% of cancer patients should have more than
one hospitalization in the last month of life” [10].
To enable a valid comparison between countries, the
quality indicator scores were standardized for patients’
gender, age at death, and cancer type, using the distribu-
tion observed in the study population as a whole as the
reference distribution.
To test whether these quality indicator scores differed
significantly between the patients who received palliative
care from their GP and those who did not, we used a
Mann Whitney U test for “the percentage of time spent
in hospital” and a Fisher’s Exact test for “the proportion
with more than one hospitalization in the last 30 days of
life”. Standardization of the quality indicator scores to
enable valid comparison between the two groups was
not applied, since the two groups did not differ signifi-
cantly in terms of gender, age at death, and cancer type.
The analyses were performed using IBM SPSS Statistics
software, Version 20.0 (IBM Corp., 2011, Armonk, NY),
with significance level α <0.05.
Results
Description of the sample
The total sample in this study consisted of 1798 patients:
500 for Belgium, 310 for the Netherlands, 764 for Italy
and 224 for Spain (see Figure 1). In all countries, the
majority of the patients in the samples were male. About
one fifth of the Italian and Spanish samples were aged
85 or older, whereas this group of the very elderly was
smaller in Belgium (13.9%) and the Netherlands (11.3%)
(Table 1). Lung cancer and colorectal cancer were the
most common types of cancer in all four countries
(Table 1). The proportion of cancer patients in each coun-
try receiving palliative care from their GP ranged from
61.4% (Belgium) to 73.9% (the Netherlands) (Table 1).
Overall, GPs knew where the patient was residing in
the last 30 days of life in 96% of the cases. The
Figure 1 Flowchart of the sample selection.














Female 210 (42.0) 138 (44.8) 344 (45.0) 69 (31.1)
Male 290 (58.0) 170 (55.2) 420 (55.0) 153 (68.9)
Age at death†
18-64 years 150 (30.3) 88 (28.4) 180 (23.6) 51 (22.8)
65-84 years 276 (55.8) 187 (60.3) 430 (56.3) 132 (58.9)
85 years and older 69 (13.9) 35 (11.3) 154 (20.2) 41 (18.3)
Cancer type‡
Lung cancer 135 (27.0) 78 (26.4) 174 (27.6) 44 (20.2)
Breast cancer 39 (7.8) 30 (10.2) 51 (8.1) 11 (5.0)
Colorectal cancer 59 (11.8) 34 (11.5) 92 (14.6) 42 (19.3)
Prostate cancer 20 (4.0) 22 (7.5) 30 (4.8) 22 (10.1)
Other 247 (49.4) 131 (44.4) 283 (44.9) 99 (45.4)
GP provided palliative care§
No 193 (38.6) 79 (26.1) 277 (36.3) 62 (28.8)
Yes 307 (61.4) 224 (73.9) 486 (63.7) 153 (71.2)
*Missing values: Belgium no missing values, the Netherlands N = 2, Italy no missing values, Spain N = 2.
†Missing values: Belgium N = 5, the Netherlands, Italy and Spain no missing values.
‡Missing values: Belgium no missing values, the Netherlands N = 15, Italy N = 134, Spain N = 6.
§Missing values: Belgium no missing values, the Netherlands N = 7, Italy N = 1, Spain N = 9.
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resided was lowest in the Netherlands (1%), and highest
in Spain (14%). GPs in Belgium and Italy did not know
where the patient resided in the last month of life for 3%
of their patients (not shown in Tables).Quality indicator “the percentage of time spent in hospital”
The Netherlands had the lowest percentage of time
spent in hospital in the last month of life (14.1%), and
Belgium the highest percentage (24.6%) (Table 2). If we
compare quality indicator scores between the cancer pa-
tient group who did receive GP palliative care and the
group who did not, we see that in all countries the qual-
ity indicator scores are significantly lower, i.e. less time
was spent in hospital, for the group that received GP
palliative care (Table 2). Only the group of cancer pa-
tients who received palliative care from their GP in the
Netherlands met the performance standard of 10%, as
they spent only 7.5% of their last month in hospital.Quality indicator “the proportion with more than one
hospitalization in the last 30 days of life”
The Netherlands had the lowest proportion with more
than one hospitalization in the final month of life (0.6%),
followed by Italy (3.1%). Spain (4.0%) and Belgium
(5.4%) had a higher proportion of multiple hospitaliza-
tions (Table 2). The performance standard of less than
4% was thus met in two countries: the Netherlands and
Italy (Table 2).
There were fewer rehospitalizations among the group
of cancer patients who received GP palliative care, al-
though a significant difference was only found in Italy
(Table 2). The performance standard of 4% was met for
the patients receiving GP palliative care in three coun-
tries: the Netherlands (0.4%), Italy (2.1%), and Spain
(3.3%). The Belgian score of 4.2% almost met the per-
formance standard. In the Netherlands, the performanceTable 2 Quality indicator scores per country and comparing c
and those who did not
“Percentage of time spen
in the last month of life (
Performance Standard*,† <10%
Belgium The Netherland
Total population per country‡ 24.6 14.1
Did not receive palliative care from the GP§ 39.7|| 34.7||
Received palliative carefrom the GP§ 16.1|| 7.5||
*Performance standard for the quality indicator “the percentage of time spent in ho
†Performance standard for the for the quality indicator “the percentage of patients
‡These percentages are standardized for gender, age and cancer type.
§These percentages are not standardized for gender, age and cancer type, since the
each country.
||Mann Whitney U test showed significant difference, p < 0.001.
¶Fisher’s Exact test showed significant difference, p < 0.05.standard was also met for the group of patients who did
not receive palliative care from their GP (Table 2).
Discussion
The percentage of time spent in hospital during the last
month of life varied between the four countries, ranging
from 14.1% (the Netherlands) to 24.6% (Belgium),
while the proportion of patients with more than one
hospitalization ranged from 0.6% (the Netherlands) to
5.4% (Belgium). The group of patients who received
palliative care from their GP spent significantly less time
in hospital and had fewer hospitalizations in the last
month of life.
The original studies presenting these quality indicators
[1,9-11] also specified a performance standard. For the
indicator concerning the time spent in hospital in the
last month of life, none of the four countries met the
performance standard (i.e. less than 10% of time should
be spent in hospital) in our study. One could argue that
we did not evaluate the performance of home palliative
care, as was the case in the original study in Italy [9] and
therefore cannot apply this this performance standard to
our data, because while patients were living at home in
our study, they were not necessarily receiving home
palliative care. Nevertheless, even when we calculated
the quality indicator scores for the patients who received
palliative care from their GP, only the Netherlands
(7.5%) met this performance standard. This could raise
the question of whether a new performance standard
needs to be defined when measuring this quality indica-
tor nationwide. In this case, an alternative could be to
apply the “best-practice norm” principle: take the best-
scoring country’s score as the target other countries
should aim for in the future.
For the other indicator, concerning the percentage of
cancer patients who were hospitalized more than once
in the last month of life, the performance standard (i.e.
less than 4% of cancer patients should have more thanancer patients who received palliative care from their GP
t in hospital”
%)
“Proportion with more than one hospitalization
in the last 30 days of life” (%)
<4%
s Italy Spain Belgium The Netherlands Italy Spain
22.2 17.7 5.4 0.6 3.1 4.0
29.3|| 32.3|| 8.3 1.3 5.1¶ 8.1
18.7|| 11.8|| 4.2 0.4 2.1¶ 3.3
spital” in the last month of life is 10% [9].
who had more than 1 hospitalization in the last month of life” is 4% [1,10,11].
se characteristics did not differ significantly between the two groups in
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achieved in two of the four countries in our study (i.e.
Spain and Belgium, with 4.0% and 5.4% of patients re-
spectively having more than one hospitalization in the last
month). This suggests this performance standard is a
feasible goal and can be used as such in the future. The
performance standard could even be updated following re-
peated measurements of these quality indicators, resulting
in continuous quality improvement [10].
The between-country differences in quality indicator
scores found in this study may reflect differences be-
tween these countries in the organization of palliative
care. One of these differences may be the role of the GP
in the provision of health care in general, and especially
in the provision of palliative care. The high degree of re-
sponsibility assigned to GPs in the Netherlands, both as
general gatekeepers [14] and specifically in the delivery
of palliative care [16,17], could be a reason for the fact
that hospitalizations in the Netherlands are shorter and
rehospitalizations are less frequent. Spain and Belgium
have comparable rates, suggesting that the general gate-
keeper function of the GP in Spain [14] may not have as
much effect on hospitalizations as the fact that the
organization of palliative care is the shared responsibility
of both GPs and palliative home-care teams [27]. The
latter is also the case in Belgium [15]. Despite the fact
that in Italy palliative home care is mainly provided by
multidisciplinary home teams [18,19], the percentage of
time spent in hospital in Italy is relatively high: 22.2%.
Another study following an Italian cohort and US cohort
in the year after the diagnosis of cancer revealed that the
number of hospital admissions was the same in both
countries but the mean number of days spent in hospital
in Italy was double that of the US cohort [13]. Two
potential causes were suggested: the fact that in Italy
patients also stay in hospital for e.g. pre-intervention
diagnostic tests, whereas in the US these tests were per-
formed in an out-patient setting; and the fact that hos-
pice programs in the US are more established than in
Italy, possibly resulting in a higher number of hospitali-
zations for end-of-life care in Italy [13].
This is in line with the important finding of this
study that among the group of patients where the GP
provided palliative care, less time was spent in hospital
in the last month of life, and multiple hospitalizations
were less frequent. We cannot provide insight into the
causality in this association due to the design of the
study. It might be that patients could stay at home be-
cause they insisted on staying at home, had an infor-
mal caregiver at home, or had a low symptom burden,
and therefore were in the right place to get palliative
care from their GP. Nevertheless, this finding high-
lights the importance of the GP in the organization
of palliative care, and the challenge for the GP andhome-care services to reduce the number of poten-
tially avoidable hospitalizations.
Strengths and limitations
This is the first cross-national study using existing data
to compare the length and number of hospitalizations in
the last month of life, and to assess their function as qual-
ity indicators. A strength of the study is that it seems feas-
ible to calculate the scores of these two quality indicators
based on data gathered by GPs, as GPs knew where the
patient was residing in the last 30 days of life in 96% of
the non-sudden cancer deaths. Consequently, existing
GP networks are a feasible candidate for a continuous
monitor of some aspects of the quality of palliative
care. Nevertheless, there are limitations when using GP
networks to collect data. We cannot fully exclude the
inaccurate judgment by GPs of patient deaths as being
sudden and unexpected.
There may be a bias as GPs may not have been in-
formed or aware of all transfers of the patient to and
from hospital or they missed some transitions in the
course of recording the data. Due to the anonymous
coding of the data collected in the GP networks, we
could not validate this information with hospital regis-
tries or insurance data. To minimize recall bias, GPs
reported on a weekly basis.
Furthermore we do not have information on the rea-
son for hospitalizations in the last month, because we
used data recorded by existing GP networks, which did
not contain information on this subject. For the same
reason, we cannot provide information about whether
these hospitalizations were elective or via the emergency
department, nor whether they were potentially avoidable
or unavoidable. In addition, the availability of hospices
and palliative care units might influence whether pa-
tients are hospitalized or not in the last month of life.
The existing registrations used in this study did not pro-
vide any data on the availability of hospices and pallia-
tive care units and whether patients with uncontrolled
symptoms may have no choice but to be hospitalized.
Further research could examine these issues more in-
depth.
Another limitation is that GPs themselves stated
whether they had provided palliative care and we could
not examine the validity of this self-reported palliative
care provision. We have no detailed information on what
GPs considered as “providing palliative care” and were
therefore unable to verify whether these definitions were
consistent with existing expert definitions. Some GPs
may consider care for patients with chronic diseases as
palliative care, whereas other consider this as regular GP
care. Therefore this study reflects the delivery of what
GPs themselves perceive to be palliative care. However,
as our study is limited to deceased cancer patients, inter-
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study of all deceased patients.
Conclusion
“The percentage of time spent in hospital” in the last
month of life and “the proportion with more than one
hospitalization in the last 30 days of life” are quality in-
dicators that can be collected with the use of existing
sentinel networks of GPs. Quality indicator scores reveal
substantial differences between countries, reflecting
country-specific differences in the organization of pallia-
tive care. In the group of patients who received palliative
care from their GP, there were fewer hospitalizations
and significantly less time was spent in hospital in the
last month, highlighting the important role of the GP in
palliative care provision.
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